Primary Insomnia
Conditions
Interventions
Trial group:Take 15 tablets of Shunqi Buxin Shiyiwei Pills orally before bedtime,take continuously for 30 days.
Control group:Take 3 mg of zopiclone tablets orally before bedtime,take continuously for 30 days.
Sponsors
Inner Mongolia International Mongolian Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Meets diagnostic criteria for primary insomnia in Western medicine and Heyi Piansheng-type insomnia in Mongolian medicine; 2. Age 18 1 month; 4. PSQI score > 7 points; 5.Patients must be conscious and able to complete assessment questionnaires; 6.Patients who voluntarily enroll in the clinical study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Secondary insomnia caused by physical illness or mental disorders; 2. Individuals working night shifts or with irregular sleep schedules; 3.Hamilton Depression Rating Scale (HAMD-17) >=17, Hamilton Anxiety Rating Scale (HAMA) >=14; 4.Pregnant or lactating women; 5.Individuals with abnormal liver or kidney function; 6.Those currently receiving other insomnia-related treatments or using sleep-inducing medications;
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Insomnia Severity Index,ISI;Actigraphy monitoring: total sleep time, sleep efficiency, number of awakenings during the night, sleep latency, and wake time after sleep onset;Serum cortisol at 8:00 AM; | — |
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index, PSQI;Mongolian Medicine Syndrome Rating Scale; | — |
Countries
China
Contacts
Public ContactDai Xuemei
Inner Mongolia International Mongolian Medicine Hospital
Outcome results
None listed